Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports

Abstract Background Although indomethacin (IND) is the standard treatment for hemodynamically significant patent ductus arteriosus (hsPDA) in Japan, it may be associated with renal impairment and gastrointestinal complications. The use of paracetamol for hsPDA closure has recently incre...

詳細記述

書誌詳細

出版年:	American Journal of Perinatology Reports
主要な著者:	Shun Matsumura, Ayumi Oshima, Sumie Fujinuma, Kosuke Tanaka, Nobuhiko Nagano, Fuyu Miyake, Satoshi Masutani, Masanori Tamura, Keiko Ueda, Fumihiko Namba
フォーマット:	論文
言語:	英語
出版事項:	Thieme Medical Publishers, Inc. 2017-10-01
主題:	indomethacin paracetamol patent ductus arteriosus premature infant surgical closure
オンライン･アクセス:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1615260